Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes

Multiple Sclerosis

Volumn 16, Issue 1, 2010, Pages 62-67

  Zipoli, Valentina ^a   Goretti, Benedetta ^a   Hakiki, Bahia ^a   Siracusa, Gianfranco ^a   Sorbi, Sandro ^a   Portaccio, Emilio ^a   Amato, Maria Pia ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Clinically isolated syndromes; Cognitive impairment; Multiple sclerosis

Indexed keywords

OLIGOCLONAL BAND;

ADULT; ARTICLE; COGNITIVE DEFECT; DEPRESSION; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADULT; AGE OF ONSET; BRAIN; COGNITION DISORDERS; COHORT STUDIES; COLOR PERCEPTION; DATA INTERPRETATION, STATISTICAL; DEPRESSION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 73949147808     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509350311     Document Type: Article

References (33)

1. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 ; 50: 121-127.
2. Polman CH, Reingold SC, Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 2005 ; 58: 840-846.
3. Coyle PK Early treatment of multiple sclerosis to prevent neurologic damage. Neurology 2008 ; 71 (24 Suppl 3). S3-7.
4. Miller D., Barkhof F., Montalban X., Thompson A., Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005 ; 4: 281-288. (Pubitemid 40545039)
5. Achiron A., Barak Y. Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 2003 ; 74: 443-446.
6. Glanz B., Holland C., Gauthier S., et al. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 2007 ; 13: 1004-1010.
7. Callanan MM, Logsdail SJ, Ron MA, Warrington EK Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study. Brain 1989 ; 112: 361-374.
8. Feinstein A., Youl B., Ron M. Acute optic neuritis. A cognitive and magnetic resonance imaging study. Brain 1992 ; 115: 1403-4315.
9. Potagas C., Giogkaraki E., Koutsis G., et al. Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 2008 ; 267: 100-106.
10. Feuillet L., Reuter F., Audoin B., et al. Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2007 ; 13: 124-127.
11. Rao S. A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Milwaukee, WI, USA: Medical College of Wisconsin, 1990.
12. Barbarotto R., Laiacona M., Frosio R., Vecchio M., Farinato A., Capitani E. A normative study on visual reaction times and two Stroop colour-word tests. Ital J Neurol Sci 1998 ; 19: 161-170.
13. Lezak M. Neuropsychological Assessment, 2 nd edn. New York: Oxford University Press, 1983.
14. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 ; 134: 382-389.
15. Krupp LB, LaRocca NG, Muir-Nash J., Steinberg AD The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989 ; 46: 1121-1123.
16. Amato MP, Portaccio E., Goretti B., et al. The Raos Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler 2006 ; 12: 787-793.
17. Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000 ; 343: 898-904.
18. Comi G., Filippi M., Barkhof F., et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001 ; 357: 1576-1582.
19. Kappos L., Polman CH, Freedman MS, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006 ; 67: 1242-1249.
20. Brex PA, Ciccarelli O., ORiordan JI, Sailer M., Thompson AJ, Miller DH A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002 ; 346: 158-164.
21. Morrissey SP, Miller DH, Kendall BE, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 1993 ; 116: 135-146.
22. ORiordan JI, Thompson AJ, Kingsley DP, et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 1998 ; 121: 495-503.
23. Tintore M., Rovira A., Rio J., et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003 ; 60: 27-30.
24. Kappos L., Freedman MS, Polman CH, et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007 ; 370: 389-397.
25. Glanz BI, Holland CM, Gauthier SA, et al. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 2007 ; Sept; 13: 1004-1010.
26. Bar-Zohar D., Agosta F., Goldstaub D., Filippi M. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives. Mult Scler 2008 ; 14: 719-727.
27. Lanz M., Hahn HK, Hildebrandt H. Brain atrophy and cognitive impairment in multiple sclerosis: a review. J Neurol 2007 ; 254 (Suppl 2). 1143-1148.
28. De Stefano N., Matthews PM, Filippi M., et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003 ; 60: 1157-1162.
29. Amato MP, Portaccio E., Goretti B., et al. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch Neurol 2007 ; 64: 1157-1161.
30. Amato MP, Bartolozzi ML, Zipoli V., et al. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004 ; 63: 89-93.
31. Amato MP, Ponziani G., Pracucci G., Bracco L., Siracusa G., Amaducci L. Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol 1995 ; 52: 168-172.
32. Rao SM, Leo GJ, Ellington L., Nauertz T., Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991 ; 41: 692-696.
33. Langdon DW, Thompson AJ Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 1999 ; 5: 94-100.